Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

I. Hyodo · SciRah

Researcher profile · Semantic Scholar

I. Hyodo

Share profile

I. Hyodo — researcher profile on SciRah

h-index: 51
Works: 419
Citations: 13K

Most-cited papers

Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial.
K. Shitara, M. Özgüroğlu, Y. Bang, M. Di Bartolomeo +149 more
2018The Lancet1,101 citations Open access
Semantic Scholar
Randomized, Phase II Study of Trastuzumab Beyond Progression in Patients With HER2-Positive Advanced Gastric or Gastroesophageal Junction Cancer: WJOG7112G (T-ACT Study).
A. Makiyama, Y. Sukawa, T. Kashiwada, J. Kawada +18 more
2020Journal of Clinical Oncology168 citations
Semantic Scholar
Surgical Outcome and Prognostic Stratification for Pulmonary Metastasis From Colorectal Cancer.
T. Okumura, N. Boku, T. Hishida, Y. Ohde +6 more
2017Annals of Thoracic Surgery93 citations Open access
Semantic Scholar
S-1 plus leucovorin and oxaliplatin versus S-1 plus cisplatin as first-line therapy in patients with advanced gastric cancer (SOLAR): a randomised, open-label, phase 3 trial.
Yoon-Koo Kang, K. Chin, H. Chung, S. Kadowaki +15 more
2020The Lancet Oncology68 citations Open access
Semantic Scholar
Randomised phase II trial of mFOLFOX6 plus bevacizumab versus mFOLFOX6 plus cetuximab as first-line treatment for colorectal liver metastasis (ATOM trial)
E. Oki, Y. Emi, T. Yamanaka, H. Uetake +15 more
2019British Journal of Cancer55 citations Open access
Semantic Scholar
Randomized phase II/III study of 5-fluorouracil/l-leucovorin versus 5-fluorouracil/l-leucovorin plus paclitaxel administered to patients with severe peritoneal metastases of gastric cancer (JCOG1108/WJOG7312G)
T. Nakajima, K. Yamaguchi, N. Boku, I. Hyodo +10 more
2020Gastric Cancer42 citations Open access
Semantic Scholar
Five-weekly S-1 plus cisplatin therapy combined with trastuzumab therapy in HER2-positive gastric cancer: a phase II trial and biomarker study (WJOG7212G)
Y. Miura, Y. Sukawa, S. Hironaka, Misuzu Mori +25 more
2017Gastric Cancer42 citations Open access
Semantic Scholar
Does Repeated Lung Resection Provide Long-Term Survival for Recurrent Pulmonary Metastases of Colorectal Cancer? Results of a Retrospective Japanese Multicenter Study.
T. Hishida, M. Tsuboi, T. Okumura, N. Boku +6 more
2017Annals of Thoracic Surgery41 citations
Semantic Scholar
A randomized phase II study of weekly paclitaxel ± trastuzumab in patients with HER2-positive advanced gastric or gastro-esophageal junction cancer refractory to trastuzumab combined with fluoropyrimidine and platinum: WJOG7112G (T-ACT).
A. Makiyama, K. Sagara, J. Kawada, T. Kashiwada +16 more
201835 citations
Semantic Scholar
Efficacy of adjuvant chemotherapy after resection of pulmonary metastasis from colorectal cancer: a propensity score-matched analysis.
Mamiko Imanishi, Yoshiyuki Yamamoto, Yukako Hamano, Takeshi Yamada +6 more
2019European Journal of Cancer33 citations
Semantic Scholar
Safety, tolerability, pharmacokinetics, and pharmacodynamics of the afucosylated, humanized anti-EPHA2 antibody DS-8895a: a first-in-human phase I dose escalation and dose expansion study in patients with advanced solid tumors
K. Shitara, T. Satoh, S. Iwasa, K. Yamaguchi +11 more
2019Journal of Immunotherapy for Cancer29 citations Open access
Semantic Scholar
TAS-118 (S-1 plus leucovorin) versus S-1 in patients with gemcitabine-refractory advanced pancreatic cancer: a randomised, open-label, phase 3 study (GRAPE trial).
T. Ioka, M. Ueno, H. Ueno, Joonoh Park +21 more
2019European Journal of Cancer26 citations Open access
Semantic Scholar
Newly developed endoscopic detachable snare ligation therapy for colonic diverticular hemorrhage: a multicenter phase II trial (with videos).
Daisuke Akutsu, T. Narasaka, Katsumasa Kobayashi, K. Matsuda +10 more
2018Gastrointestinal Endoscopy24 citations
Semantic Scholar
Augmented antitumor activity of 5‐fluorouracil by double knockdown of MDM4 and MDM2 in colon and gastric cancer cells
Mamiko Imanishi, Yoshiyuki Yamamoto, Xiaoxuan Wang, A. Sugaya +5 more
2019Cancer Science23 citations Open access
Semantic Scholar
Retrospective analysis for the efficacy and safety of nivolumab in advanced gastric cancer patients according to ascites burden
Hirosumi Suzuki, Takeshi Yamada, A. Sugaya, Shunsuke Ueyama +3 more
2020International Journal of Clinical Oncology22 citations
Semantic Scholar
Early tumor shrinkage and depth of response in patients with advanced gastric cancer: a retrospective analysis of a randomized phase III study of first-line S-1 plus oxaliplatin vs. S-1 plus cisplatin
T. Nishina, M. Azuma, K. Nishikawa, M. Gotoh +18 more
2018Gastric Cancer22 citations Open access
Semantic Scholar
Acetic acid is an oxidative stressor in gastric cancer cells
M. Terasaki, H. Ito, H. Kurokawa, M. Tamura +3 more
2018Journal of clinical biochemistry and nutrition22 citations Open access
Semantic Scholar
Phase II Study (NO LIMIT, WJOG13320G) of First-Line Nivolumab Plus Low-Dose Ipilimumab for Microsatellite Instability-High Advanced Gastric or Esophagogastric Junction Cancer.
H. Kawakami, S. Kadowaki, A. Makiyama, Masahiro Tsuda +14 more
2025Journal of Clinical Oncology20 citations
Semantic Scholar
Randomised phase II study of panitumumab plus irinotecan versus cetuximab plus irinotecan in patients with KRAS wild-type metastatic colorectal cancer refractory to fluoropyrimidine, irinotecan and oxaliplatin (WJOG 6510G).
D. Sakai, H. Taniguchi, N. Sugimoto, T. Tamura +35 more
2020European Journal of Cancer19 citations
Semantic Scholar
Outcomes and prognostic factors after pulmonary metastasectomy in patients with colorectal cancer with previously resected hepatic metastases
Kimihiro Shimizu, Y. Ohtaki, T. Okumura, N. Boku +6 more
2019Journal of Thoracic and Cardiovascular Surgery19 citations Open access
Semantic Scholar
A placebo-controlled, double-blind, randomized study of recombinant thrombomodulin (ART-123) to prevent oxaliplatin-induced peripheral neuropathy
M. Kotaka, Y. Saito, Takeshi Kato, H. Satake +15 more
2020Cancer Chemotherapy and Pharmacology18 citations Open access
Semantic Scholar
Safety margin of radiofrequency ablation for hepatocellular carcinoma: a prospective study using magnetic resonance imaging with superparamagnetic iron oxide
Kuniaki Fukuda, K. Mori, Naoyuki Hasegawa, K. Nasu +6 more
2019Japanese Journal of Radiology18 citations
Semantic Scholar
Sex differences in the safety of S‐1 plus oxaliplatin and S‐1 plus cisplatin for patients with metastatic gastric cancer
Yasuhide Yamada, W. Koizumi, K. Nishikawa, M. Gotoh +16 more
2019Cancer Science16 citations Open access
Semantic Scholar
Prospective observational study of the efficacy of oral uracil and tegafur plus leucovorin for stage II colon cancer with risk factors for recurrence using propensity score matching (JFMC46-1201)
S. Sadahiro, Kazuhiro Sakamoto, T. Tsuchiya, Takao Takahashi +16 more
2022BMC Cancer15 citations Open access
Semantic Scholar
Association of ERBB2 Copy Number and Gene Coalterations With Trastuzumab Efficacy and Resistance in Human Epidermal Growth Factor Receptor 2–Positive Esophagogastric and Gastric Cancer
K. Hino, T. Nishina, T. Kajiwara, H. Bando +18 more
2022JCO Precision Oncology14 citations Open access
Semantic Scholar
Possible involvement of zinc deficiency in epidermal growth factor receptor inhibitor‐induced xerotic dermatitis
Mikiko Tohyama, Chihiro Sakaguchi, T. Nishina, I. Hyodo
2021Journal of dermatology (Print)14 citations Open access
Semantic Scholar
Chemoprevention against colon cancer by dietary intake of sulforaphane
A. Yanaka, Hideo Suzuki, M. Mutoh, T. Kamoshida +5 more
2019Functional Foods in Health and Disease12 citations Open access
Semantic Scholar
First-line chemotherapy with S-1 alone or S-1 plus cisplatin for elderly patients with advanced gastric cancer: a multicenter propensity score matched study
A. Makiyama, K. Kunieda, M. Noguchi, T. Kajiwara +31 more
2018Gastric Cancer12 citations Open access
Semantic Scholar
Gut microbiome associated with PARP inhibitor efficacy in patients with ovarian cancer
Mika Okazawa-Sakai, Shunsuke A. Sakai, I. Hyodo, S. Horasawa +21 more
2024Journal of Gynecologic Oncology11 citations
Semantic Scholar
Enhanced G1 arrest and apoptosis via MDM4/MDM2 double knockdown and MEK inhibition in wild-type TP53 colon and gastric cancer cells with aberrant KRAS signaling
Xiaoxuan Wang, Yoshiyuki Yamamoto, Mamiko Imanishi, Xiaochen Zhang +8 more
2021Oncology Letters10 citations Open access
Semantic Scholar
Time-dependent discrepancies between physician-assessed and patient-reported oxaliplatin-induced peripheral neuropathy in patients with metastatic colorectal cancer who received mFOLFOX6 plus bevacizumab: a post hoc analysis (WJOG4407GSS2)
Y. Miura, M. Ando, K. Yamazaki, S. Hironaka +3 more
2020Supportive Care in Cancer10 citations
Semantic Scholar
Anal canal adenocarcinoma with neuroendocrine features accompanying secondary extramammary Paget disease, successfully treated with modified FOLFOX6: a case report
Masamichi Yamaura, Takeshi Yamada, R. Watanabe, Hitomi Kawai +8 more
2018BMC Cancer10 citations Open access
Semantic Scholar
Oncolytic Virotherapy and Gene Therapy Strategies for Hepatobiliary Cancers.
Takeshi Yamada, Yukako Hamano, Naoyuki Hasegawa, Emiko Seo +4 more
2017Current Cancer Drug Targets10 citations
Semantic Scholar
Waterjet submucosal dissection of porcine esophagus with the HybridKnife and ERBEJET 2 system: a pilot study
Daisuke Akutsu, Hideo Suzuki, T. Narasaka, M. Terasaki +4 more
2017Endoscopy International Open10 citations Open access
Semantic Scholar
Simple prognostic markers for optimal treatment of patients with unresectable pancreatic cancer
T. Terao, T. Kumagi, I. Hyodo, T. Yokota +11 more
2021Medicine9 citations Open access
Semantic Scholar
O14-1 A randomized phase II study comparing S-1 plus oxaliplatin with S-1 monotherapy for elderly patients with advanced gastric cancer: WJOG8315G
A. Makiyama, H. Shoji, H. Kawakami, Takao Tamura +15 more
2023Annals of Oncology7 citations Open access
Semantic Scholar
MDM4 as a Prognostic Factor for Patients With Gastric Cancer With Low Expression of p53
Xiaochen Zhang, Yoshiyuki Yamamoto, Xiaoxuan Wang, Masashi Sato +7 more
2021Anticancer Research7 citations Open access
Semantic Scholar
Early Tumor Shrinkage and Depth of Response in the Second-Line Treatment for KRAS exon2 Wild-Type Metastatic Colorectal Cancer: An Exploratory Analysis of the Randomized Phase 2 Trial Comparing Panitumumab and Bevacizumab in Combination with FOLFIRI (WJOG6210G)
N. Izawa, K. Shitara, K. Yonesaka, T. Yamanaka +16 more
2020Targeted oncology7 citations
Semantic Scholar
Phase II study of S-1 on alternate days plus bevacizumab in patients aged ≥ 75 years with metastatic colorectal cancer (J-SAVER)
T. Moriwaki, Y. Sakai, Hiroyasu Ishida, Yoshiyuki Yamamoto +14 more
2019International Journal of Clinical Oncology7 citations Open access
Semantic Scholar
Biomarker study for trastuzumab continuation beyond progression in a randomized phase II trial of weekly paclitaxel±trastuzumab in patients with HER2-positive advanced gastric or gastro-esophageal junction cancer refractory to trastuzumab combined with fluoropyrimidine and platinum (WJOG7112G).
Y. Sukawa, A. Makiyama, T. Esaki, Gen Hirano +16 more
20187 citations
Semantic Scholar
Prevalence and clinicopathological features of microsatellite instability-high metastatic or recurrent gastric and esophagogastric junction cancer: WJOG13320GPS
A. Komori, S. Hironaka, S. Kadowaki, S. Mitani +20 more
2024Gastric Cancer6 citations
Semantic Scholar
Nanoparticle albumin-bound paclitaxel and ramucirumab versus paclitaxel and ramucirumab as second-line chemotherapy for unresectable advanced or recurrent gastric cancer: a multicenter, propensity score-matched analysis (CROSS SELL study)
A. Nakasya, Yuya Hagiwara, T. Ikoma, Y. Kurioka +8 more
2022International Journal of Clinical Oncology6 citations Open access
Semantic Scholar
A phase III study of TAS-118 plus oxaliplatin versus S-1 plus cisplatin as first-line chemotherapy in patients with advanced gastric cancer (SOLAR study).
Yoon-Koo Kang, K. Chin, H. Chung, S. Kadowaki +16 more
2019Annals of Oncology6 citations Open access
Semantic Scholar
aCGH Analysis of Predictive Biomarkers for Response to Bevacizumab plus Oxaliplatin- or Irinotecan-Based Chemotherapy in Patients with Metastatic Colorectal Cancer.
Y. Fujita, M. Taguri, K. Yamazaki, J. Tsurutani +27 more
2018The Oncologist6 citations Open access
Semantic Scholar
Risk factors and efficacy outcomes of early-onset severe neutropenia due to paclitaxel or nanoparticle albumin-bound paclitaxel combined with ramucirumab in advanced gastric cancer: a multicenter retrospective cohort study
Yuya Hagiwara, A. Nakasya, Toshihiko Matsumoto, T. Ikoma +8 more
2022Journal of Gastrointestinal Oncology5 citations Open access
Semantic Scholar
Pathological Evaluation of Resected Colorectal Liver Metastases: mFOLFOX6 Plus Bevacizumab versus mFOLFOX6 Plus Cetuximab in the Phase II ATOM Trial
Takao Takahashi, K. Ishida, Y. Emi, M. Sakamoto +12 more
2022Cancers5 citations Open access
Semantic Scholar
Gastric neuroendocrine carcinoma presenting complete durable response by nivolumab treatment for multiple metastases and radiotherapy to oligoprogressive metastasis
Yusuke Seyama, Takeshi Yamada, Hirosumi Suzuki, Satoshi Fukuda +6 more
2023International Cancer Conference Journal4 citations Open access
Semantic Scholar
Prospective observational study of zinc deficiency symptoms during first-line chemotherapy for gastric and colorectal cancer
Chihiro Sakaguchi, T. Nishina, Y. Kono, K. Hino +9 more
2023Journal of Gastrointestinal Oncology4 citations Open access
Semantic Scholar
A robust culture method for maintaining tumorigenic cancer stem cells in the hepatocellular carcinoma cell line Li‐7
Yukako Sato, Takeshi Yamada, T. Hiroyama, K. Sudo +3 more
2019Cancer Science4 citations Open access
Semantic Scholar
Plasma ICAM-1 (pICAM-1) and plasma IL-8 (pIL-8) level as biomarker of metastatic colorectal cancer patients (mCRC) treated with mFOLFOX6/XELOX plus bevacizumab (BV) (WJOG7612GTR).
Yoshiyuki Yamamoto, W. Okamoto, A. Makiyama, K. Shitara +16 more
20184 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

N. Boku×19
Invite
N. Boku — researcher profile on SciRah
T. Moriwaki×17
Invite
T. Moriwaki — researcher profile on SciRah
S. Hironaka×16
Invite
S. Hironaka — researcher profile on SciRah
K. Muro×14
Invite
K. Muro — researcher profile on SciRah

×14

Invite

T. Nishina — researcher profile on SciRah

Yoshiyuki Yamamoto×12

Invite

Yoshiyuki Yamamoto — researcher profile on SciRah

A. Makiyama×10

Invite

A. Makiyama — researcher profile on SciRah

K. Yamazaki×10

Invite

K. Yamazaki — researcher profile on SciRah

Invite

T. Esaki — researcher profile on SciRah

Invite

H. Hara — researcher profile on SciRah

Invite

A. Tsuji — researcher profile on SciRah

Invite

N. Sugimoto — researcher profile on SciRah